‘OFFERING FIRST CEREBROSPINAL FLUID-BASED ALZHEIMER’S TEST’

“We are excited about the opportunities that we envision on the horizon for in-vitro diagnostics and our pipeline. We are bringing to India the first Cerebrospinal Fluid-based Alzheimer’s test that will offer an improved diagnosis of the disease. Currently, Alzheimer’s Disease (AD) is diagnosed largely on the basis of cognitive symptoms, with a significant number of patients being diagnosed when their disease has advanced considerably. We are also looking at advanced tests catering to cardiac and women’s health areas. The pandemic has definitely brought testing into the spotlight and people are today much more aware of different diagnostic interventions that can help detect, monitor and manage diseases.”

- NARENDRA VARDE, Managing Director, Roche Diagnostics India & Neighbouring Markets